Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP439210.RAVgf0JCh7XMg5MXRU4rJ04i8epetbmv0fBPpzBV2Adqs130_assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP439210.RAVgf0JCh7XMg5MXRU4rJ04i8epetbmv0fBPpzBV2Adqs130_provenance.
• NP304350.RAVBYLJAKaEgOVJ5ayEMBWsLDtPaZOo0TbYAJXkPmxRWE130_assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304350.RAVBYLJAKaEgOVJ5ayEMBWsLDtPaZOo0TbYAJXkPmxRWE130_provenance.
• assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP905552.RAeS8kNuISbKh4ESX4lyX5lvbjzlPRCQy6BRyAQOFQrtU130_assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905552.RAeS8kNuISbKh4ESX4lyX5lvbjzlPRCQy6BRyAQOFQrtU130_provenance.
• NP905553.RAW6LgKOhh5RxtxGJ2sph1x48JhgmGJECQTudRyh8txQo130_assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905553.RAW6LgKOhh5RxtxGJ2sph1x48JhgmGJECQTudRyh8txQo130_provenance.
• NP905557.RAWS9wyp36L8bi-O10NPFZ4roghAl4Eggvw8pVxfAkRgo130_assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905557.RAWS9wyp36L8bi-O10NPFZ4roghAl4Eggvw8pVxfAkRgo130_provenance.
• NP905562.RAbaoHpQuQ6HfrD1zVowoe_-eHVTsMYkZNhs-jfZ0RxIw130_assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905562.RAbaoHpQuQ6HfrD1zVowoe_-eHVTsMYkZNhs-jfZ0RxIw130_provenance.
• NP300250.RAoQ04VDOBaA46bM9rAbSNF9y6E_4J9zPdqNvbUUyT2Pw130_assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300250.RAoQ04VDOBaA46bM9rAbSNF9y6E_4J9zPdqNvbUUyT2Pw130_provenance.
• NP905551.RACLql7SjID-VwsC_yleaXSGiE6Pf1sRWL6gLKJYINXSQ130_assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905551.RACLql7SjID-VwsC_yleaXSGiE6Pf1sRWL6gLKJYINXSQ130_provenance.
• NP441174.RAhOvi3cn4TMWgsIDdggKT5C7qpkPmgibKEDsDztGopx0130_assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP441174.RAhOvi3cn4TMWgsIDdggKT5C7qpkPmgibKEDsDztGopx0130_provenance.
• NP441219.RAqdGeWhRHsDPuuLSOxCqoE7ttSJSK2yat1uxlrmg7dTY130_assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP441219.RAqdGeWhRHsDPuuLSOxCqoE7ttSJSK2yat1uxlrmg7dTY130_provenance.
• NP441389.RAlCKNq826Phikahdcx-SZMTu4ev32hroMZ1LEta4ZYJQ130_assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP441389.RAlCKNq826Phikahdcx-SZMTu4ev32hroMZ1LEta4ZYJQ130_provenance.
• NP905558.RAgUqk2mPgCpswpIwtd-JDG3IaTE3CSCQXGbkY08yAXS4130_assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905558.RAgUqk2mPgCpswpIwtd-JDG3IaTE3CSCQXGbkY08yAXS4130_provenance.
• NP905559.RAqOECeMQXaKrwmIkn39hDYwQrlwGN94cou3iuWYg1WJc130_assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905559.RAqOECeMQXaKrwmIkn39hDYwQrlwGN94cou3iuWYg1WJc130_provenance.
• NP905560.RAu65oyzcCOlIgY_XdKWDck-oPdkybGhp2M4jLPUbhu18130_assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905560.RAu65oyzcCOlIgY_XdKWDck-oPdkybGhp2M4jLPUbhu18130_provenance.
• NP609703.RAMQ-qHV56273L4iUZXKmia1fZYQTeQLPRpWhdqRSwHC8130_assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP609703.RAMQ-qHV56273L4iUZXKmia1fZYQTeQLPRpWhdqRSwHC8130_provenance.
• NP905554.RA7lhtRncspuaD0MTSVBNyYptnr-6ReMWHJYC2RXZmTB0130_assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905554.RA7lhtRncspuaD0MTSVBNyYptnr-6ReMWHJYC2RXZmTB0130_provenance.
• NP905555.RA_m6mDTET0sDn9iRgVD5a8JYc86K53F-s3QcnhzvmqUs130_assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905555.RA_m6mDTET0sDn9iRgVD5a8JYc86K53F-s3QcnhzvmqUs130_provenance.
• NP905563.RA19PBFGQWC7U2NUpYU6vc6JN43DpmOMo2nJruWciOFg0130_assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905563.RA19PBFGQWC7U2NUpYU6vc6JN43DpmOMo2nJruWciOFg0130_provenance.